首页> 外文OA文献 >Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies
【2h】

Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies

机译:通过没有血红蛋白的单个红细胞性重新编程红细胞性研究,为镰状细胞疾病进行三种控制IPS细胞系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sickle cell disease (SCD) is one of the most prevalent and severe monogenetic disorders. Previously, we generated iPS cell lines from SCD patients. Here, we generated iPS cell lines from three age-, ethnicity- and gender-matched healthy individuals as control cell lines. Cell reprogramming was performed using erythroblasts expanded from PBMC by a non-integrative method. SCD-iPSC controls expressed pluripotency markers, presented a normal karyotype, were able to differentiate into the three germ layers in embryoid body spontaneous differentiation and confirmed to be integration-free. The cell lines generated here may be used as matched healthy controls for SCD studies.
机译:镰状细胞疾病(SCD)是最普遍和严重的单一的单一疾病之一。以前,我们生成了SCD患者的IPS细胞系。在这里,我们从三岁,种族和性别匹配的健康个体中产生IPS细胞系作为对照细胞系。使用从PBMC膨胀的红细胞通过非共同化方法进行细胞重编程。 SCD-IPSC对照表达多能性标记物,呈现正常的核型,能够区分胚胎体自发分化中的三种胚层,并确认是无一体的。这里产生的细胞系可以用作SCD研究的匹配健康对照。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号